CLOV Clover Health Investments Corp
Price (delayed)
$2.77
Market cap
$1.38B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.27
Enterprise value
$1.13B
Clover Health is a healthcare technology company with a deeply rooted mission of improving every life. Clover uses its proprietary technology platform to collect, structure, and analyze health and behavioral
Highlights
Clover Health Investments's gross margin has surged by 133% YoY and by 7% QoQ
Clover Health Investments's quick ratio has surged by 100% YoY and by 14% QoQ
The revenue has contracted by 29% YoY but it has grown by 2.2% from the previous quarter
Key stats
What are the main financial stats of CLOV
Market
Valuations
Earnings
Shares outstanding
497.47M
Market cap
$1.38B
Enterprise value
$1.13B
Price to earnings (P/E)
N/A
Price to book (P/B)
4.23
Price to sales (P/S)
0.8
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.66
Revenue
$1.7B
EBIT
-$123.7M
EBITDA
-$121.82M
Free cash flow
-$178.21M
Per share
Balance sheet
Liquidity
EPS
-$0.27
Free cash flow per share
-$0.37
Book value per share
$0.65
Revenue per share
$3.48
TBVPS
$1.38
Total assets
$674.21M
Total liabilities
$349.32M
Debt
$4.01M
Equity
$324.89M
Working capital
$225.07M
Debt to equity
0.01
Current ratio
1.69
Quick ratio
1.44
Net debt/EBITDA
2.06
Margins
Efficiency
Dividend
EBITDA margin
-7.2%
Gross margin
18.6%
Net margin
-7.3%
Operating margin
-7.2%
Return on assets
-16.6%
Return on equity
-40.4%
Return on invested capital
-115.9%
Return on capital employed
-35.4%
Return on sales
-7.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
CLOV stock price
How has the Clover Health Investments stock price performed over time
Intraday
4.53%
1 week
4.14%
1 month
48.13%
1 year
108.27%
YTD
190.94%
QTD
125.2%
Financial performance
How have Clover Health Investments's revenue and profit performed over time
Revenue
$1.7B
Gross profit
$315.34M
Operating income
-$122.65M
Net income
-$123.7M
Gross margin
18.6%
Net margin
-7.3%
Clover Health Investments's gross margin has surged by 133% YoY and by 7% QoQ
The gross profit has surged by 65% year-on-year and by 9% since the previous quarter
The operating income has soared by 58% YoY and by 23% from the previous quarter
The net income has soared by 53% year-on-year and by 23% since the previous quarter
Growth
What is Clover Health Investments's growth rate over time
Valuation
What is Clover Health Investments stock price valuation
P/E
N/A
P/B
4.23
P/S
0.8
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.66
CLOV's EPS has surged by 52% year-on-year and by 21% since the previous quarter
The P/B is 153% above the last 4 quarters average of 1.6
The equity has grown by 11% from the previous quarter
The P/S is 153% above the last 4 quarters average of 0.3 but 42% below the 5-year quarterly average of 1.3
The revenue has contracted by 29% YoY but it has grown by 2.2% from the previous quarter
Efficiency
How efficient is Clover Health Investments business performance
CLOV's ROE is up by 46% YoY and by 22% from the previous quarter
The return on invested capital is up by 45% year-on-year and by 35% since the previous quarter
CLOV's return on sales is up by 33% year-on-year and by 24% since the previous quarter
The ROA has grown by 19% YoY and by 8% from the previous quarter
Dividends
What is CLOV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for CLOV.
Financial health
How did Clover Health Investments financials performed over time
CLOV's total assets is 93% greater than its total liabilities
Clover Health Investments's quick ratio has surged by 100% YoY and by 14% QoQ
Clover Health Investments's total liabilities has plunged by 62% YoY and by 8% from the previous quarter
The debt is 99% less than the equity
The debt to equity has plunged by 50% YoY
The debt has contracted by 25% YoY and by 8% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.